Company / Total Debt
IRONWOOD PHARMACEUTICALS INC Total Debt History
FY2020-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Debt
$396.3M
FY2022
5-year range
$396.3M / $454.2M
FY2020-FY2022
Trend
-12.8%
vs FY2021
Sector context
#31 of 83
Health Care
What the data says
At $396M, IRONWOOD PHARMACEUTICALS INC's total debt ranks #53 of 83 in the Health Care sector. Improved from $430M to $396M over the past 2 years.
Based on SEC 10-K filings.
$396M in FY2022.
Improved from $430M to $396M over the past 2 years.
Health Care sector context is included.
Total Debt over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#53 of 83 in Health CareTop 63% of 83This company $396.3M Sector average $6.2B
▼
-93.6% below sector average
Key checks
Key Insights
- In FY2022, total debt decreased 12.8% year-over-year.
- Ranks #31 out of 83 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score -2.17 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total DebtValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | $396.3M | -12.8% |
| FY2021 | $454.2M | +5.6% |
| FY2020 | $430.3M | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2022 · SEC 10-K · Updated Jun 30, 2026